Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Celsion Corporation 

997 Lenox Drive
Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 609-896-9100 Fax: 609-896-2200


Medical Device

 Company News
Celsion Corporation (CLSN) Announces Updated Overall Survival Data from HEAT Study of ThermoDox In Primary Liver Cancer 2/23/2015 6:46:43 AM
Celsion Corporation (CLSN) Presents Clinical And Preclinical Data For GEN-1 IL-12 Immunotherapy In Ovarian Cancer At The Molecular Medicine TRI-Conference 2/20/2015 10:31:09 AM
Celsion Corporation (CLSN) And myTomorrows Partner To Introduce Thermodox® Early Access Program In Europe For Patients With Recurrent Chest Wall Breast Cancer 1/20/2015 8:15:14 AM
Celsion Corporation (CLSN) Submits DNA-Based Immunotherapy Clinical Protocol To The FDA As Part Of A First Line Treatment For Ovarian Cancer 1/6/2015 7:40:30 AM
Celsion Corporation (CLSN) Reports Third Quarter 2014 Financial Results 11/11/2014 8:33:22 AM
Celsion Corporation (CLSN) Receives VHP Approval To Initiate OPTIMA Study In Europe 11/5/2014 7:29:42 AM
Celsion Corporation (CLSN) To Hold Third Quarter 2014 Financial Results Conference Call On Tuesday, November 11, 2014 11/4/2014 9:03:51 AM
Celsion Corporation (CLSN) Presents Preclinical Data For Its TheraSilence™ Platform At The miRNA World Conference Workshop On miRNA Delivery 10/29/2014 8:09:48 AM
Celsion Corporation (CLSN) Announces Appointment Of Michael H. Tardugno To Executive Chairman Of The Board Of Directors 10/8/2014 8:21:48 AM
Celsion Corporation (CLSN) Announces The Unexpected Passing Of Max E. Link, Ph.D., Chairman Of The Board 10/8/2014 8:19:01 AM